7MAX
SARS-CoV-2 Main Protease (Mpro) in Complex with Covalent Inhibitor SM137
Summary for 7MAX
Entry DOI | 10.2210/pdb7max/pdb |
Descriptor | 3C-like proteinase, D-phenylalanyl-N-{(2R)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-4-fluoro-L-phenylalaninamide (3 entities in total) |
Functional Keywords | sars-cov-2, covid-19, covid19 protease, protease inhibitor, covalent inhibitor, complex, hydrolase inhibitor complex, hydrolase, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
Biological source | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2) |
Total number of polymer chains | 2 |
Total formula weight | 68732.35 |
Authors | Lockbaum, G.J.,Schiffer, C.A. (deposition date: 2021-03-31, release date: 2022-10-12, Last modification date: 2024-11-06) |
Primary citation | Lockbaum, G.J.,Schiffer, C.A. SARS-CoV-2 Main Protease (Mpro) in Complex with Covalent Inhibitor SM137 To Be Published, |
Experimental method | X-RAY DIFFRACTION (1.98 Å) |
Structure validation
Download full validation report